The basic principles of immunosuppressive therapy after kidney transplantation
The article deals with medical and organizational issues of individually-adapted immunosuppressive therapy in renal allograft recipients. In the recent years, the basis of nephroprotective therapy schemes includes m-TOR inhibitors. The accessibility of these drugs for those in need is limited. Meanw...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
2018-03-01
|
Series: | Трансплантология (Москва) |
Subjects: | |
Online Access: | https://www.jtransplantologiya.ru/jour/article/view/215 |
Summary: | The article deals with medical and organizational issues of individually-adapted immunosuppressive therapy in renal allograft recipients. In the recent years, the basis of nephroprotective therapy schemes includes m-TOR inhibitors. The accessibility of these drugs for those in need is limited. Meanwhile, a more widespread use of these drugs in clinical transplantation would both increase the life span of a transplanted kidney, and reduce the risk of viral infections and cancer in the long-term after kidney transplantation, and would also allow a rational use of budget funds for the treatment of such patients. |
---|---|
ISSN: | 2074-0506 2542-0909 |